RecruitingNCT00557726

Diagnosis and Management of Inflammatory and Infectious Diseases


Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

400 participants

Start Date

Feb 17, 1978

Study Type

OBSERVATIONAL

Conditions

Summary

This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocol studies. Such patients will be admitted to the protocol and handled according to accepted medical practice of diagnosis and treatment.


Eligibility

Min Age: 3 YearsMax Age: 100 Years

Inclusion Criteria5

  • Known or suspected exposure to infection, as determined by the Principal Investigator OR Presence of signs and symptoms of an infectious or inflammatory disease
  • Age range: 3 years of age and older.
  • NIAID/LIR investigator who has an interest in the patient s illness and is willing to serve as attending physician to supervise the patient's medical care at the NIH.
  • Primary physician outside the NIH
  • The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18

Exclusion Criteria2

  • Pregnant.
  • Presence of conditions that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00557726


Related Trials